Integrated meta-analysis, network pharmacology, and molecular docking to investigate the efficacy and potential pharmacological mechanism of Kai-Xin-San on Alzheimer's disease
Context Kai-Xin-San (KXS) has been used to treat Alzheimer’s disease (AD) for thousands of years. However, no quantitative data regarding AD treatment using KXS are available. Moreover, its active compounds and mechanism of action for the treatment of AD remain largely unclear. Objectives To evaluat...
Main Authors: | Pengji Yi, Zheyu Zhang, Siqi Huang, Jiahua Huang, Weijun Peng, Jingjing Yang |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2020-01-01
|
Series: | Pharmaceutical Biology |
Subjects: | |
Online Access: | http://dx.doi.org/10.1080/13880209.2020.1817103 |
Similar Items
-
A network pharmacology-based strategy deciphers the underlying molecular mechanisms of Qixuehe Capsule in the treatment of menstrual disorders
by: Yanqiong Zhang, et al.
Published: (2017-08-01) -
Molecular mechanism of Huaihuasan in treatment of ulcerative colitis based on network pharmacology and molecular docking
by: Yi Wu, et al.
Published: (2021-08-01) -
Systems Pharmacology Approach to Investigate the Mechanism of Kai-Xin-San in Alzheimer’s Disease
by: Yunxia Luo, et al.
Published: (2020-04-01) -
Potential mechanism of Ziyin Tongluo Formula in the treatment of postmenopausal osteoporosis: based on network pharmacology and ovariectomized rat model
by: Rong-Bin Chen, et al.
Published: (2021-09-01) -
Exploring the Mechanism of Gyejibokryeong-hwan against Atherosclerosis Using Network Pharmacology and Molecular Docking
by: A Yeong Lee, et al.
Published: (2020-12-01)